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Proteins destined for the cell surface are first as-
sessed in the endoplasmic reticulum (ER) for proper
folding before release into the secretory pathway.
This ensures that defective proteins are normally
prevented from entering the extracellular environ-
ment, where they could be disruptive. Here, we
report that, when ER folding capacity is saturated
during stress, misfolded glycosylphosphatidylinosi-
tol-anchored proteins dissociate from resident ER
chaperones, engage export receptors, and quantita-
tively leave the ER via vesicular transport to the
Golgi. Clearance from the ER commences within mi-
nutes of acute ER stress, before the transcriptional
component of the unfolded protein response is acti-
vated. These aberrant proteins then access the cell
surface transiently before destruction in lysosomes.
Inhibiting this stress-induced pathway by depleting
the ER-export receptors leads to aggregation of the
ER-retained misfolded protein. Thus, this rapid
response alleviates the elevated burden of misfolded
proteins in the ER at the onset of ER stress, promot-
ing protein homeostasis in the ER.
INTRODUCTION
Newly synthesized secretory andmembrane proteins that do not
pass quality control at the endoplasmic reticulum (ER) are typi-
cally retained by resident chaperones and routed to ER-associ-
ated degradation (ERAD) pathways (Hegde and Ploegh, 2010).
Under some conditions, the burden of nascent unfolded and
misfolded proteins in the ER increases beyond its processing
capacity, leading to ER stress (Schro¨der and Kaufman, 2005).
This activates the unfolded protein response (UPR), a multi-
pronged signaling pathway that transcriptionally upregulates
factors involved in expanding the ER protein folding capacity
(Ron and Walter, 2007).522 Cell 158, 522–533, July 31, 2014 ª2014 The AuthorsAlthough the UPR can restore protein folding homeostasis,
the temporal lag of the transcriptional response (typically hours)
raises the question of how protein quality control is achieved for
misfolded proteins present in the ER during the acute phase
of ER stress. Although the simplest answer is degradation by
ERAD, these pathways would likely be temporarily saturated.
Furthermore, recent work on mammalian prion protein (PrP)
has suggested that at least some misfolded proteins may not
be good substrates for ERAD.
PrP is a widely expressed cell surface glycosylphosphatidyli-
nositol (GPI) anchored protein. Although the normal function of
PrP is uncertain, its misfolding is causative of various diseases
(Aguzzi et al., 2008; Prusiner, 1998). Among these, numerous
natural and artificial misfolding or mislocalization mutants lead
to neurodegeneration in both mice and humans (Kova´cs et al.,
2002). Despite the importance of PrP misfolding in disease,
the various pathways of misfolded PrP degradation are not
well established.
Intriguingly, many PrP mutants that enter the ER lumen
were found to be poorly degraded by ERAD, apparently relying
instead on lysosomes (Ashok and Hegde, 2009). A notable
exception was the situation in which addition of PrP’s GPI-
anchorwasblocked by eithermutation or genetic perturbation, in
which case the unprocessed PrP was routed efficiently for ERAD
(Ashok and Hegde, 2008). These observations hinted at the pos-
sibility that GPI-anchoredmisfolded PrPwas degraded by an un-
defined non-ERAD route. Such a pathway might be especially
important during ER stress, a frequently encountered condition
in vivo, including during PrP-induced neurodegeneration (Hetz
and Soto, 2006). These considerations motivated us to investi-
gate the fate of misfolded PrP along with other unrelated mis-
folded GPI-anchored proteins during acute ER stress.
Our experiments led us to a heretofore unappreciated
pathway that clears a diverse range of misfolded GPI-anchored
proteins from the ER within minutes of ER stress. These mis-
folded proteins synchronously enter the secretory pathway and
briefly transit the plasma membrane before their final targeting
to lysosomes for destruction. Knockdown of themajor ER export
factor, Tmp21, prevents this stress-induced egress, resulting in
misfolded protein aggregation in the ER. The wide conservation
Figure 1. ER Stress Induces Rapid Relocali-
zation and Degradation of ER-Retained
Misfolded PrP
(A) Diagrams of YFP-tagged wild-type PrP (YFP-
PrP) and YFP-tagged misfolded PrP (YFP-PrP*)
depicting the GPI-anchor (yellow), two N-linked
glycans (blue), the disulfide bond (black), and the
YFP-tag (green). YFP-PrP* lacks the intramolecular
disulfide bond.
(B) Steady-state localization of YFP-PrP (left) and
YFP-PrP* (right). CFP-KDEL marks the ER.
(C) Time-lapse images of YFP-PrP*-expressing
cells after treatment with thapsigargin (TG, top) or
with dithiothreitol (DTT, bottom)
(D) Steady-state chase experiment performed
using YFP-PrP*-expressing cells. The top panel
shows an autoradiograph of YFP-PrP* immuno-
precipitations from a representative experiment,
and the bottom panel shows quantification from
multiple experiments (mean ± SE; n = 4).
Scale bars, 10 mm. See also Movies S1 and S2 and
Figure S1.of the GPI anchor in all eukaryotes and the fact that mammals
express more than 150 different GPI-anchored proteins of crit-
ical function (Fujita and Kinoshita, 2012) highlight the importance
of our findings.
RESULTS
Stress-Induced Clearance of ER-Retained Misfolded
PrP for Lysosomal Degradation
We created a constitutively misfolding variant of PrP, hereafter
named PrP*, by perturbing the essential disulfide bond between
cysteine residues 179 and 214 with a C179A point mutation
(Figure 1A). PrP* was fluorescent protein (FP) tagged at a site
previously shown not to disrupt wild-type PrP folding or traf-
ficking (Ashok and Hegde, 2009). Our construct was equipped
with the prolactin signal sequence to ensure efficient translo-
cation into the ER (Kang et al., 2006) and stably expressed in
cultured cells at physiological levels (Figure S1A available
online). In contrast to cell-surface localized wild-type YFP-PrP,
constitutively misfolded YFP-PrP* was almost entirely retained
in the ER at steady state in multiple cell types (Figures 1B,
S1B, and S1C).
Upon application of two independent ER stressors, thapsigar-
gin (TG) and dithiothreitol (DTT), live-cell time-lapse imaging
revealed rapid relocalization of YFP-PrP* from the ER to
a perinuclear locale (within 10–30 min), distributed puncta
(within 30–60 min), and disappearance from those puncta (by
60–120 min) (Figure 1C and Movies S1 and S2). Biochemical
analysis of radiolabeled YFP-PrP* verified that acute ER stress
accelerates its degradation relative to untreated cells (Figure 1D).
As we discovered later (see below), untreated cells also employ
the same degradation pathway at low levels, explaining
why50% of YFP-PrP* is lost by 90 min. Similar stress-
enhanced degradation was observed for other disulfide mutants
of PrP, including C179S, C214A, or C214S (data not shown)
and human disease mutants of PrP (described below). Thus,misfolded PrPs residing in the ER at the onset of acute ER stress
are rapidly degraded by a pathway involving its relocalization.
An inhibitor of secretory traffic, brefeldin A (BFA) (Klausner
et al., 1992), blocked the ER-stress-induced relocalization of
PrP*, suggesting that ER export was involved (Figure 2A). Coloc-
alization experiments at different times after stress induction
showed that YFP-PrP* transits successively through the ER,
ER exit sites, ER-Golgi intermediate compartment, Golgi, and
lysosomes (Figure 2B). YFP-PrP* followed the same itinerary in
multiple cell types derived from different tissues (Figures S1B
and S1C).
Quantitative microscopy of the trafficking pathway that YFP-
PrP* followed during ER stress revealed that more than 80%
of the protein resided solely in post-ER compartments prior
to being degraded (Figure S1D). This suggests that ERAD path-
ways are not a major determinant of PrP* degradation during
ER stress. Instead, its lysosomal localization prior to disappear-
ance indicated that lysosomes are the major site of PrP* degra-
dation (Figures 2B and 2C). Interfering with lysosomal function
by inhibiting either its resident proteases or its acidification
(with bafilomycin A1) increased PrP* accumulation in lyso-
somes (Figures 2C and S2A–2C). Immunoblotting analysis veri-
fied that full-length YFP-PrP* was indeed stabilized with BFA,
lysosomal inhibitor, or bafilomycin A1 treatments (Figures 2D
and S2D).
Of note, we determined that autophagy does not play a role in
relocalization of YFP-PrP* to lysosomes by using bafilomycin A1,
which blocks autophagosome fusion with lysosomes in addition
to inhibiting lysosomal degradation (Yamamoto et al., 1998).
YFP-PrP* accumulated within lysosomes rather than in autopha-
gosomes under these conditions (Figure S2E). Furthermore, inhi-
bition of autophagy with 3-methyladenine had no effect on PrP*
relocalization to lysosomes (data not shown).
These results reveal a stress-induced process for export
of misfolded ER-retained proteins to downstream compart-
ments of the secretory pathway for subsequent lysosomalCell 158, 522–533, July 31, 2014 ª2014 The Authors 523
Figure 2. PrP* Undergoes Rapid ER Stress-Induced Export for Subsequent Lysosomal Degradation
(A) Cells cotransfected with CFP-KDEL and YFP-PrP* were treated with brefeldin A (BFA) and TG, and time-lapse images were collected.
(B) Cells were cotransfected with YFP-PrP* and a CFP-tagged fusion of the indicated organelle marker. Images of different cells were collected at the indicated
times after TG treatment. KDEL, Sec13, ERGIC53, GalT, and LAMP1 each respectively mark the ER, ER exit sites, ER-Golgi intermediate compartment, Golgi,
and lysosomes.
(C) YFP-PrP* and LAMP1-CFP-expressing cells were treatedwith TG or TG plus lysosomal protease inhibitors, and time-lapse imageswere taken. The inset at the
2 hr time point shows a magnified view of the region marked by the box. Complete data set in Figure S2B.
(D) Representative western blot (middle) and quantification (top) from lysates of YFP-PrP*-expressing cells that were either treated with TG alone (+TG), TG plus
protease inhibitors (TG+PI), or TG plus BFA. Densitometry of YFP-PrP* was normalized using the Ponceau S stained blot (bottom).
Scale bars, 10 mm. See also Figures S1 and S2.
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Figure 3. PrP* Traffics to the Plasma Mem-
brane during RESET
(A) Time-lapse images of YFP-PrP*-expressing
cells treated with TG + methyl-b-cyclodextrin
(MbCD) (top) or TG alone (bottom) taken at two
different focal planes. Mid-cell indicates a focal
plane at the widest point of the nucleus and
coverslip indicates a focal plane close to the
coverslip where the largest portion of the plasma
membrane is in focus.
(B) YFP-PrP* cells were untreated or treated with
TG and MbCD and then fixed after 90 min
and stained with anti-GFP antibody without per-
meabilization to detect cell surface YFP-PrP*.
(C) Antibody uptake assay for internalization of
YFP-PrP* from the plasma membrane. YFP-PrP*-
expressing or untransfected (Untf’d) cells were
treated for 1 hr with TG in the presence of leu-
peptin and either anti-GFP or anti-Myc. The cells
were then washed, fixed, permeabilized, and
stained with Cy5-conjugated secondary antibody
to detect internalized antibody.
Scale bars, 10 mm.degradation. We term this ER-clearance process RESET (for
rapid ER stress-induced export) to distinguish it from qualita-
tively different ER-clearance pathways that involve ERAD or
autophagy.
Misfolded PrP Accesses the Cell Surface during Transit
to Lysosomes
Trafficking to lysosomes can either be direct from the Golgi
or indirect via the plasma membrane (Arvan et al., 2002; Luzio
et al., 2003). To see whether YFP-PrP* accesses the cell sur-
face en route to lysosomes, we inhibited the major endocytosis
pathways with the cholesterol-depleting agent methyl-b-cyclo-
dextrin (MbCD) (Kirkham and Parton, 2005; Rodal et al., 1999).
When YFP-PrP* molecules were released from the ER with
stress in the presence of MbCD, a substantial proportion of
these molecules was observed to be trapped at the plasma
membrane (Figure 3A) and accessible to extracellular antibody
(Figure 3B). Antibody uptake assays in the absence of MbCD
verified that stress-released YFP-PrP* that ultimately arrived
in lysosomes had sampled the cell surface (Figure 3C). ItsCell 158, 522–apparent short residence time at the
plasma membrane relative to wild-type
PrP (Figure 1B) implicates poorly under-
stood quality control pathways at the
plasma membrane for selective internal-
ization and destruction in lysosomes.
Diverse Misfolded GPI-Anchored
Proteins Access the RESET
Pathway
The ER-retained T cell receptor subunit,
CD3d, was not exported during acute
ER stress (Figure 4A) and instead was
degraded by ERAD (Klausner et al.,
1990). This suggested that RESET maybe dependent on a feature of the ER quality control substrate.
Domain analysis of YFP-PrP* revealed that one element regu-
lating its RESET is the GPI anchor. Either preventing GPI-anchor
addition (with the processing site mutation S232W [Ashok and
Hegde, 2008]) or deleting the GPI-anchoring signal resulted in
an ER-retained misfolded protein that was not exported to
downstream compartments of the secretory pathway during
stress (Figure 4B). By contrast, RESET was unaffected by pre-
venting N-linked glycosylation of YFP-PrP* (with mutations to
both asparagines, N181T and N197T) (Figure 4B) or eliminating
the YFP-tag (Figure S3A).
We tested whether the GPI anchor may be a general signal to
route misfolded proteins for RESET by examining artificial and
naturally occurring mutants of GPI-anchored proteins whose
GFP-tagged wild-type versions traffic normally to the plasma
membrane (Figure 4C). The ER-retained pool of disulfide mu-
tants of three unrelated GPI-anchored proteins—CD59, Thy1,
and DAF—underwent RESET (Figure 4D). Importantly, RESET
was not limited to artificial mutants but also was seen with
several human disease-associated mutants (Figures 4E and533, July 31, 2014 ª2014 The Authors 525
Figure 4. Diverse GPI-Anchored Proteins
Undergo ER Stress-Induced Export
(A) Time-lapse images captured after addition of
TG to cells stably expressing the ERAD substrate
YFP-CD3d.
(B) Time-lapse images after TG addition to cells
expressing the indicated YFP-PrP* mutants.
N181T/N197T prevents both N-glycosylations,
S232stop truncates the GPI-anchor signal
sequence, and S232W blocks processing of the
GPI-anchor signal sequence.
(C) Steady-state localization of the indicated GFP-
tagged wild-type GPI-anchored proteins.
(D and E) Time-lapse images after TG addition to
cells expressing the indicated mutants of GPI-
anchored proteins. Experiments were performed
48 hr after transfection.
(D) Artificial mutants include GFP-tagged CD59
(C94S, to disrupt one of five potential internal di-
sulfide bonds), Thy1 (C28A, to disrupt one of three
potential internal disulfide bonds), and decay
accelerating factor (DAF, C81A, to disrupt one of
eight potential internal disulfide bonds).
(E) Naturally occurring human disease mutants
include PrP (D202N), PrP (F198S), CD59 (C89Y),
and FolR (C65W).
Scale bars, 10 mm. See also Figure S3.S3B). These include the D202N and F198S mutants in PrP
(Gu et al., 2007; Ivanova et al., 2001), the C89Y mutant in
CD59 (Nevo et al., 2013), and the C65Wmutant in folate receptor
1 (Grapp et al., 2012). These results suggest that GPI-anchored
proteins represent a major client set for RESET.
This conclusion is consistent with old observations on the fate
of the transmembrane TCR-a, an unassembled T cell receptor
subunit and ERAD substrate (Suzuki et al., 1991). Although a sol-
uble truncated version of TCR-a lacking the cytosolic and trans-
membrane domains (TCR-at) was found to be retained in
the ER in thapsigargin-treated cells, a variant in which TCR-at
is appended to a GPI-anchor (TCR-aGPI) is exported to the
cell surface. We verified this result and found that RESET of
TCR-aGPI is seen with either thapsigargin- or DTT-mediated ER
stress (Figure S3C). Thus, an ERAD substrate can be converted
to a RESET substrate solely by the addition of a GPI-anchor,
identifying this as at least one major feature of a RESET client.
RESET Clients Utilize Tmp21-Mediated ER Export
We next determined the mechanistic basis of RESET. RESET
presumably operates by switching from retention of the mis-526 Cell 158, 522–533, July 31, 2014 ª2014 The Authorsfolded protein in the ER under non-
stressed conditions to egress during ER
stress. This implies the existence of a
retention factor and an export receptor.
A candidate retention factor for YFP-
PrP* was identified by immunoprecipita-
tion and mass spectrometry. In these
experiments, we looked for ER-resident
interaction partners that release very
shortly after application of ER stressors.
An 90 kD band first detected in radiola-
beled coimmunoprecipitation experiments (Figures S4A–S4F)
was identified by mass spectrometry as calnexin, an ER-resi-
dent chaperone (Bergeron et al., 1994). The reliance on a
GPI-anchor for RESET of YFP-PrP* implicated the p24 family
of export receptors for GPI-anchored protein trafficking (Bon-
non et al., 2010; Schimmo¨ller et al., 1995; Takida et al.,
2008). We therefore scrutinized these factors for their potential
role in RESET.
Coimmunoprecipitation experiments showed that calnexin as-
sociates with YFP-PrP*, but not as strongly with wild-type YFP-
PrP, suggesting a misfolding-dependent interaction (Figures 5A
and S4C). The p24 family member, Tmp21, interacted with both
misfolded and wild-type PrPs (Figure 5A). By contrast, the unre-
lated ER export receptor ERGIC53 showed no interaction with
either YFP-PrP* or YFP-PrP, providing a specificity control.
The interactions with Tmp21 and calnexin were strongly depen-
dent on the GPI anchor (Figure 5B), which is consistent with their
potential role in RESET.
Upon induction of ER stress, the interaction with calnexin
was lost, whereas the Tmp21 interaction was maintained (Fig-
ure 5C). YFP-PrP* egress proved to be dependent on Tmp21,
Figure 5. PrP* Releases fromCalnexin upon
ER Stress for Tmp21-Dependent Export
(A–C) Cells stably expressing the indicated PrP
constructs were subjected to GFP pull-downs and
input (I) and eluate (E) fractions analyzed by
western blot for the indicated proteins, including
calnexin (CNX), Tmp21, and p58/ERGIC53. Un-
transfected cells (Untf’d) served as a negative
control. In (A), YFP-PrP-expressing cells were
treated with BFA for 3 hr to retain newly synthe-
sized YFP-PrP in the ER. In (C), TG treatment,
where indicated, was for 30 min.
(D) Western blot of YFP-PrP* cells treated with
nontargeting (NT) or Tmp21 siRNA probed for
Tmp21, YFP-PrP*, or tubulin.
(E) Cells expressing either YFP-PrP* (left) or YFP-
PrP (right) were subjected to siRNA treatment
against Tmp21 and analyzed for YFP localization
and Tmp21 immunofluorescence. Each panel
shows two adjacent cells in the same field of view
where one cell was depleted for Tmp21 and the
other cell was not. YFP-PrP* cells were treated
with TG for 30 min prior to fixation, whereas YFP-
PrP cells were treated with BFA for 3 hr, released
for 60 min, and then fixed. Quantification of mul-
tiple fields showed that YFP-PrP* was ER localized
in all Tmp21-depleted cells (n = 133), but Golgi
localized in Tmp21-expressing cells (n = 117).
By contrast, YFP-PrP was detected in vesicular
compartments and the plasma membrane
regardless of Tmp21 knockdown (n = 200).
(F) Time-lapse images after TG treatment of YFP-
PrP* in a cell knocked down for Tmp21. Identical
results were obtained in50%of all cells (n = 112),
which is consistent with the proportion of cells
successfully knocked down for Tmp21.
Scale bars, 10 mm. See also Figure S4.as evidenced by a strong failure in RESET in Tmp21 knockdown
cells (Figures 5D–5F). Similarly, calnexin and Tmp21 interaction
were observed for misfolded CD59 (Figure S4G), and depen-
dence on Tmp21 for stress-induced ER export was shown for
CD59 (Figure S4H) and TCR-aGPI (Figure S4I). Collectively, these
results demonstrate that Tmp21 plays a key role in the RESET of
misfolded GPI-anchored proteins.
Notably, wild-type PrP and CD59 showed no gross defects
in their steady-state plasma membrane localization in Tmp21
knockdown cells (Figures 5D and S4H). This is consistent
with an earlier study that showed only a mild kinetic delay in
wild-type GPI-anchored protein trafficking in the absence of
Tmp21 (Takida et al., 2008). The far stronger dependence on
Tmp21 for misfolded GPI-anchored protein ER export impli-
cates a role for Tmp21 in maintenance of ER protein folding
homeostasis.Cell 158, 522–ER Stress Drives Aggregation
of Misfolded PrP in the ER of
Tmp21-Depleted Cells
To clarify the physiologic role of
RESET in maintaining ER homeostasis,
we depleted Tmp21 and assessed the
biochemical and biophysical propertiesof ER-retained PrP*. YFP-PrP* in unstressed Tmp21 knockdown
cells was associated with calnexin by coimmunoprecipitation
(Figure 6A) and is predominantly soluble in nondenaturing deter-
gents (Figure 6B). Upon ER stress, the calnexin interaction was
lost (Figure 6A), despite the fact that YFP-PrP* does not exit
the ER in Tmp21 knockdown cells (Figures 5D–5F). This loss of
chaperone interactionwas accompanied by YFP-PrP* becoming
substantially detergent insoluble (Figure 6B), suggesting that it
had partially aggregated.
In cells containing Tmp21, YPF-PrP* would exit the ER upon
ER stress, thereby escaping aggregation in the ER. To test
whether YFP-PrP* aggregation in Tmp21 knockdown cells was
simply a consequence of preventing this exit, we analyzed con-
trol cells subjected to ER stress in the presence of BFA to pre-
vent ER export (Figure 6C). Instead of aggregating, YFP-PrP*
remained largely soluble under these conditions. This suggests533, July 31, 2014 ª2014 The Authors 527
Figure 6. PrP* Aggregates in the ER upon Selective Inhibition of RESET
(A) YFP-PrP*-expressing cells were subjected to Tmp21 siRNA and treated with TG for 30minwhere indicated and subjected to GFP pull-downs. The input (I) and
eluate (E) fractions were analyzed by immunoblotting for the indicated proteins.
(B) YFP-PrP*-expressing cells subjected to Tmp21 siRNA were treated for 60 min with TG or DTT as indicated. Their cell lysates were separated into soluble (S)
and insoluble (I) fractions and analyzed by western blot for YFP-PrP*. The percent insoluble was calculated from three experiments and shown below the gel
(mean ± SE).
(C) YFP-PrP*-expressing cells were treated with BFA, BFA plus TG, or BFA plus DTT for 60 min and analyzed as in (B).
(D) FRAP analysis was performed on YFP-PrP* in untreated cells or cells depleted for Tmp21 (Tmp21 k/d) with or without 60 min of TG treatment. Average
normalized fluorescence intensity values were fit to an exponential curve to determine recovery half-times (t1/2). Error bars indicate SE.
(E) Table of half-times and mobile fractions compiling data from (C) and from Figures S5A–5C for comparison.
See also Figure S5.that Tmp21, beyond simply exporting YFP-PrP* out of a stressed
ER, plays a role in precluding its aggregation. Such a function
for Tmp21 may be due to its direct interaction with YFP-PrP*,
although this remains to be examined in future studies.
In addition to the biochemical analysis, we studied the diffu-
sion properties of YFP-PrP* in live cells using fluorescence
recovery after photobleaching (FRAP) (Figures 6D and 6E).
YFP-PrP* in the ER of unstressed cells, with or without Tmp21
knockdown, displayed rapid diffusion with a t1/2 of fluorescence
recovery of 3 s. By contrast, YFP-PrP* in the stressed ER of
Tmp21 knockdown cells had a nearly 5-fold slower recovery
rate with a t1/2 of 14 s. Importantly, ER stress caused at most
a modest change in mobility for YFP-CD3d, YFP-PrP*, or wild-
type YFP-PrP retained in the ER by BFA (Figures 6E and S5A–
S5C). Thus, a dramatic reduction of diffusion is selective to the
RESET substrate PrP* and depends on the triad of ER stress,
Tmp21 depletion, and PrP misfolding.
The results from the solubility assays and FRAP analyses are
consistent with amodel wherein Tmp21-mediated RESET is crit-
ical for avoiding PrP* aggregation in the ER during ER stress (Fig-
ure S5D). Accordingly, in wild-type cells, most PrP* is maintained
in a soluble state through its interaction with ER chaperones,
whereas under acute ER stress conditions, when chaperone528 Cell 158, 522–533, July 31, 2014 ª2014 The Authorsavailability is limiting, PrP* can bind to Tmp21. Tmp21-PrP* inter-
action fulfills two parallel functions: (1) maintaining PrP* in a sol-
uble state and (2) facilitating PrP* export from the ER. In support
of this model, Tmp21 depletion leads to PrP* retention in the ER
and its aggregation in stressed cells, whereas in cells in which
Tmp21 is available, PrP* that is retained in the ER by BFA treat-
ment does not aggregate with stress.
Relationship between RESET and the Unfolded Protein
Response
To explore the relationship between RESET and the UPR, we
generated a YFP-PrP*-expressing cell line that was stably
transfected with an XBP1-mCherry reporter for UPR induction
(Brunsing et al., 2008). ER stress activates Ire1 to initiate the
UPR by splicing XBP1 mRNA, allowing for expression of the
XBP1 transcription factor (Yoshida et al., 2001). Therefore, we
could simultaneously monitor in live cells the RESET of PrP*
and the ER stress response, as revealed by XBP1-mCherry
fluorescence.
Induction of ER stress at a point when most YFP-PrP* was in
the ER triggered RESET of YFP-PrP* within minutes, whereas
XBP1-mCherry was detectably produced starting at 3 hr (Figures
7A and S6A). UPR induction was maximal from between 4 and
Figure 7. The ER Stress Response Modulates ER Export of YFP-PrP*
(A) Cells stably expressing XBP1-mCherry were transiently transfected with GFP-PrP* and, 48 hr later, treated with DTT. Shown are time-lapse images over the
course of 18 hr starting 5 min after addition of DTT. Extended time lapse series data are shown in Figure S6A.
(B) Nonpermeabilized YFP-PrP*-expressing cells were untreated (left) or treated withMbCD (right) for 90min and then fixed and stained with anti-GFP antibody to
detect YFP-PrP* exposed on the cell surface.
(C) Cells were transfected with YFP-PrP*, ER marker CFP-KDEL, and lysosomal marker LAMP1-mCherry and, 48 hr after transfection, were either left untreated
(left) or incubated for 6 hr with leupeptin (+LEU) prior to imaging. The boxes indicate the regions that are magnified on the right side of each panel.
(D) Images at different time points after transient transfection with YFP-PrP* in cells stably expressing the Golgi marker, GalT-CFP.
(E) An experiment as in (D) imaged for a longer time (see Movie S3).
(F) Western blots of N2a cells 48 hr after YFP-PrP* transfection, 8 hr after 0.5 mM DTT treatment (DTT), or from untransfected and untreated cells (untreated).
Approximately equal loading was confirmed by Ponceau S (Pon S) staining. The red asterisks indicate the positions of XBP1 and CHOP.
Scale bars, 10 mm. See also Figure S6 and Movie S3.10 hr, after which it declined. Remarkably, localization of PrP*
began reverting to the ER within 3.5 hr, and after 10 hr, PrP*
predominantly localized to the ER. Thus, RESET appears to be
most active during the window of time when ER function iscompromised and before the cell has compensated via UPR
action. After UPR-mediated gene expression begins to restore
ER homeostasis, most of the PrP* is again found to be retained
in the ER.Cell 158, 522–533, July 31, 2014 ª2014 The Authors 529
Degradation of Misfolded GPI-Anchored Proteins in
Cells without Exogenous Stressors
Given that misfolded GPI-anchored proteins appear to be poor
ERAD clients, we investigated their degradation in the absence
of acute ER stress. Three experiments suggested that their
degradation culminates in lysosomes by a pathway similar
to RESET. First, treatment of YFP-PrP*-expressing cells with
MbCD resulted in its trapping at the plasma membrane (Fig-
ure 7B). Second, antibody uptake experiments illustrated that,
even without ER stress, YFP-PrP* accesses the extracellular
space at least transiently (data not shown). And third, inhibition
of lysosomal proteases resulted in YFP-PrP* accumulation in
puncta that colocalized with a lysosomal marker (Figure 7C).
Thus, although constitutive degradation of PrP* occurs at
a slower rate in unstressed cells such that most of the YFP-
PrP* is ER localized, the constitutive degradation pathway
shares with RESET the trafficking itinerary as well as the final
destination.
Insight into the relationship between the stress-induced and
steady-state degradation pathways came from careful examina-
tion of YFP-PrP* trafficking upon induction of its expression. We
observed that, shortly after transient transfection, most of the
newly synthesized YFP-PrP* was evidently undergoing RESET
as judged by its post-ER localization (Figure 7D and Movie S3).
At longer times after transient transfection, the cells attained a
new steady state in which most of the increased load of PrP*
could be localized to the ER (Figures 7C and 7E and Movie
S3). This phenomenon could be explained by the possibility
that transient expression of a misfolded protein is itself an ER
stressor. Indeed, detecting transcription factors downstream of
UPR stress transducers (Figure 7F) or using a luciferase reporter
of UPR activation revealed that induction of YFP-PrP* or any of
several other PrP mutants caused ER stress (Figures S6B–6D).
The level of luciferase reporter activation was roughly similar to
that observed with0.5 to 1 mMDTT (Figure S6D). This explains
why, at short times after transfection, YFP-PrP* undergoes
RESET, whereas at later time points, adaptation of cells via
UPR induction allows cells to achieve a new steady state in
which PrP* is predominantly localized to the ER.
It is worth noting that, in the adapted state, YFP-PrP* is still
being exported for lysosomal degradation via the secretory
pathway. This can be rationalized by considering that binding
and release from ER chaperones is in competition with alterna-
tive fates (Sekijima et al., 2005), such as binding to export recep-
tors like Tmp21. Thus, the balance may favor chaperones at
steady state but may shift strongly toward export when chap-
erone function is overwhelmed or compromised as during ER
stress. Furthermore, even though the cells have adapted to
YFP-PrP* expression via UPR induction, they are nevertheless
still susceptible to additional stressors that act globally by per-
turbing the folding of other proteins, explaining why YFP-PrP*
in adapted cells is rapidly routed for RESET with subsequent
DTT or thapsigargin treatment.
DISCUSSION
Our findings have revealed a previously unappreciated pathway
for degradation of misfolded GPI-anchored proteins that repre-530 Cell 158, 522–533, July 31, 2014 ª2014 The Authorssents a protective mechanism to alleviate acute ER stress. By al-
lowing a subset ofmisfolded proteins to engage cargo receptors,
the burden of misfolded proteins in the ER is rapidly reduced and
aggregation is avoided. In the case of the GPI-anchored proteins
studied here, the primary mechanism of ER retention is an
association with calnexin, whereas the primary mechanism of
egress depends on the ER export receptor Tmp21. Interestingly,
whereas folded GPI-anchored proteins can clearly use Tmp21-
independent routes for ER export (Bonnon et al., 2010; Takida
et al., 2008), misfolded GPI-anchored proteins seem to be
strongly dependent on Tmp21. This may explain the constitutive
ER stress phenotype seen in Tmp21-deficient cells ofDrosophila
and yeast (Belden and Barlowe, 2001; Boltz and Carney, 2008;
Jonikas et al., 2009) and the early embryonic lethality of Tmp21
knockout mice (Denzel et al., 2000).
The discovery that ER stress triggers the dramatic escape
of misfolded, GPI-anchored proteins from the ER to the Golgi
was unexpected. Most other reports show that treatment with
ER stressors results in tight binding of ER-localized proteins to
ER chaperones (Kim and Arvan, 1995; Ma and Hendershot,
2004). The mechanistic basis for this difference is likely to hinge
on two major determinants: a misfolded domain and a GPI
anchor. Although neither the misfolded domain nor the GPI an-
chor is sufficient alone, they collude to permit RESET for multiple
unrelated proteins through a requisite interaction with Tmp21.
Notably, the folding status of the GPI-anchored protein ap-
peared to influence its dependence on Tmp21 for ER export.
Whereas surface localization of wild-type PrP or CD59 was not
appreciably affected by Tmp21 knockdown, ER export of the
misfolded variants of PrP and CD59 was severely compromised.
At present, the basis of this discrimination is not clear and merits
further investigation. One possible explanation may be related to
the observed ability of Tmp21 to prevent PrP* aggregation in the
ER independently of mediating its export. Tmp21, either directly
or in conjunction with other factors, maintains misfolded PrP in a
soluble state. Thus, Tmp21 may act as a chaperone to bind mis-
folded GPI-anchored proteins, preventing inappropriate interac-
tions and ensuring safe passage through the secretory pathway
en route to lysosomes.
Tmp21 is a type 1 transmembrane protein that cycles between
the ER and Golgi and contains a cytosolic COPII binding signal
(Blum et al., 1996; Dominguez et al., 1998; Nickel et al., 1997).
Thus, Tmp21-mediated ER export of GPI-anchored proteins
could be explained by its ability to bridge the gap between the
GPI-anchored clients within the ER lumen and the vesicular traf-
ficking machinery on the cytosolic side. Hence, ER retention of
PrP* in Tmp21 knockdown cells could be due simply to the lack
of a suitable export receptor. Although we cannot rule out the
alternative explanation that failed export in Tmp21 knockdown
cells is a secondary consequence of an altered ER environment,
the physical interaction between Tmp21 and PrP* and previous
reports suggesting that p24 proteins facilitate GPI-anchored
protein ER export (Bonnon et al., 2010; Schimmo¨ller et al.,
1995; Takida et al., 2008) support a more direct mechanism.
It is emerging that GPI-anchored proteins may be refractory to
degradation by ERAD (Ashok and Hegde, 2009; this study). This
may be because the covalently attached lipid in the lumenal
leaflet of the lipid bilayer poses a topologic problem for ERAD
machinery. For example, earlier work clearly showed that a
PrP mutant (H187R) containing an unprocessed GPI-anchoring
signal sequence is a strong degron for ERAD, but the identical
protein containing a GPI anchor is degraded in lysosomes
(Ashok and Hegde, 2008, 2009). Similarly, the efficient ERAD
substrate TCR-a can be converted to a RESET substrate by
changing it from a transmembrane protein to a GPI-anchored
protein (Suzuki et al., 1991; this study).
The difficulty in degrading misfolded PrP from the ER and
its propensity to aggregate there under stress conditions may
explain why multiple mechanisms have evolved to prevent its
residence in the ER lumen during stress. In addition to RESET,
earlier work showed that the efficiency of PrP translocation
into the ER is reduced during ER stress (Kang et al., 2006).
This attenuation was dependent on the PrP signal peptide and,
when bypassed, led to its increased propensity to aggregate in-
side the ER. Thus, by a combination of both clearance via RESET
and attenuation of new entry, aggregation of misfolded PrP is
minimized inside the ER lumen. The extent to which these mech-
anisms apply to other GPI-anchored proteins remains to be
investigated in detail.
Stress induction simply by the expression of disease-associ-
ated PrPmutants (Figures S6B–S6D), combinedwith our discov-
ery of a RESET pathway for lysosomal degradation, may explain
why most mutant PrPs are found to be only partially retained in
the ER (Ashok and Hegde, 2009; Gu et al., 2007; Ivanova et al.,
2001). We posit that the constitutive ER stress caused bymutant
PrP expression activates RESET, at least partially, leading to
mutant PrP egress via the secretory pathway. Indeed, knock-
down of Tmp21 leads to increased ER retention of mutant PrP,
but not wild-type PrP, at steady state. The net consequence of
these effects would be a highly heterogeneous distribution of
mutant PrP in the secretory pathway, constitutive ER stress,
overall reduced plasma membrane localization, and primarily
lysosomal degradation. This is precisely the picture of mutant
PrP behavior deduced from multiple earlier analyses (Ashok
and Hegde, 2009; Gu et al., 2007; Ivanova et al., 2001; Negro
et al., 2001).
The transient appearance of PrP* on the plasma membrane
followed by rapid endocytosis and delivery to lysosomes impli-
cates post-ER quality control pathways for the disposal of mis-
folded proteins released from the ER by RESET. At present,
the mechanisms that permit the cell to distinguish folded from
misfolded GPI-anchored proteins at the plasma membrane (or
Golgi) are unknown. Although plasma membrane quality control
has been described for the integral membrane proteins CFTR
(Okiyoneda et al., 2010), an artificially constructed thermolabile
substrate (Apaja et al., 2010), and a panel of thermolabile mutant
transporters (Zhao et al., 2013), in each case, cargo recognition
begins with ubiquitination on the misfolded cytosolic domain.
GPI-anchored proteins lack a cytosolically exposed domain.
Thus, understanding how noncytosolic defects in proteins can
be detected in post-ER compartments remains an important
goal for future studies aimed at clarifying the downstream fate
of proteins undergoing RESET.
Our studies initially revealed and characterized RESET by us-
ing chemical stressors. However, several observations argue for
this pathway’s relevance in physiological situations. First, GPI-anchored proteins are abundant and ubiquitous (Ferguson
et al., 2009) with many known disease-causing misfolding vari-
ants (Grapp et al., 2012; Gu et al., 2007; Ivanova et al., 2001;
Nevo et al., 2013). Given that diverse misfolded GPI-anchored
proteins undergo RESET in multiple cell types, RESET is likely
to be a widely used mechanism for the clearance of misfolded
GPI-anchored proteins from the ER. Second, cells commonly
experience any of a variety of physiological acute stressors
such as viral infection (Diehl et al., 2011), ischema (Perman
et al., 2011), and differentiation (Reimold et al., 2001), where
RESET may act to ameliorate the imbalance in ER homeostasis
prior to UPR-mediated adaptation. This idea is supported by our
demonstration that new expression of PrP* alone, at physiolog-
ical levels without additional chemical stressors, induces acute
ER stress sufficient to induce RESET of PrP*. Subsequently,
the UPR is triggered in PrP*-expressing cells, which likely leads
to a new homeostasis, as indicated by the eventual retention of
most of the PrP* in the ER. Third, in cells that have adapted to
PrP* expression, the export pathway to lysosomes was utilized
at low levels by PrP* for constitutive degradation.
The rate of engagement of the RESET pathway is predicted to
be contingent on the dynamics of interaction between ER resi-
dent chaperones and ER export receptors. This is presumably
a continuum and is dependent on both the substrate in question
and homeostatic state of the ER (Sekijima et al., 2005). In this
view, RESET is an enhanced version of a degradation pathway
that occurs at more modest levels in the absence of exogenous
stressors. This is analogous to other aspects of ER stress re-
sponses, where physiologic changes in flux through the ER
induce modest changes in the same pathways that were first
discovered using artificial reporters and chemical stressors
(e.g., ERAD [Bonifacino and Lippincott-Schwartz, 1991] or the
UPR [Ma and Hendershot, 2001]). Our conceptual description
of RESET, along with the detailed characterization of Tmp21-
dependent RESET for GPI-anchored proteins, provides a
foundation for future exploration of its different physiologic and
pathophysiologic roles.
EXPERIMENTAL PROCEDURES
Detailed methods are provided in the Extended Experimental Procedures.
Cells, Plasmids, and siRNA
All experiments were performed in stably transfected normal rat kidney (NRK)
cells, unless specified. All cells cotransfected with organelle markers were
imaged 48 hr after transient transfection. YFP-PrP was constructed by replac-
ing the endogenous PrP signal sequence (residues 1–22) with the bovine
preprolactin-signal sequence to ensure efficient translocation into the ER
(Rane et al., 2004) and inserting mYFP into the unique Bsu36I site. Construc-
tion of eGFP-CD59, GFP-Thy1, GFP-DAF, and GFP-FolR is described in
the Extended Experimental Procedures. Misfolding mutants were derived
by site-directed mutagenesis. Tmp21 was depleted by two sequential
knockdowns within 48 hr using 50 nM concentration of ON-TARGETplus
SMARTpool Rat Tmed10 siRNA and Dharmafect 2 transfection reagent (Dhar-
macon), and experiments were performed 24 hr after the second knockdown.
Drug Treatments
Working concentrations are 0.1 mM thapsigargin, 0.5 mM dithiothreitol, 5 mM
methyl-b-cyclodextrin, and 1 mM brefeldin A. Lysosomal protease inhibitors
refer to 125 mM leupeptin + protease inhibitor cocktail (Sigma P8340) diluted
1:100.Cell 158, 522–533, July 31, 2014 ª2014 The Authors 531
Microscopy
All fixed and live-cell imaging, excluding FRAP, were performed using the
Marianas spinning disk confocal system (Intelligent Imaging Innovations)
attached to a Zeiss Observer.Z1 microscope (Carl Zeiss MicroImaging) and
analyzed by Slidebook software. FRAP was performed and analyzed with
the Zeiss LSM 710 system (Carl Zeiss MicroImaging).
Biochemistry
For steady-state chase experiments, cells were labeled for 10 hr with
100 mCi/ml 35S label (NEG072002MC, Perkin Elmer) in Cys-free/Met-free
media (D0422, Sigma) supplemented with 10% serum, 2 mM L-Glu, 0.6 mM
Cys, and 2 mM Met. Column purifications were performed with the mMACS
GFP Isolation Kit (Miltenyi Biotec) using 1% CHAPS, 50 mM HEPES
(pH 7.4), and 100 mM NaCl for cell lysis and washes.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three movies and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2014.06.026.
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